Comparison between Beta Drugs IPO and D.P.Abhushan IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while D.P.Abhushan IPO is a SME Fixed Price proposed to list at NSE SME.
| Beta Drugs IPO | D.P.Abhushan IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the D.P.Abhushan IPO is up to ₹15.77 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of D.P.Abhushan IPO is ₹28.00 per share.
| Beta Drugs IPO | D.P.Abhushan IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹28.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 4000 shares |
| Fresh Issue Size | 21,66,400 shares | 56,32,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹15.77 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 56,32,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹15.77 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while D.P.Abhushan IPO opens on Oct 09, 2017. The closing date of Beta Drugs IPO and D.P.Abhushan IPO is Oct 04, 2017, and Oct 11, 2017, respectively.
| Beta Drugs IPO | D.P.Abhushan IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Oct 09, 2017 |
| Issue Close | Oct 04, 2017 | Oct 11, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Oct 12, 2017 | Oct 23, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to D.P.Abhushan IPO P/E ratio of .
| Beta Drugs IPO | D.P.Abhushan IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹73.52 Cr. | ₹62.31 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in D.P.Abhushan IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in D.P.Abhushan IPO.
| Beta Drugs IPO | D.P.Abhushan IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,29,600 shares | 3,00,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 28,16,000 shares |
| RII | 10,83,200 shares | 28,16,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 56,32,000 shares |
Beta Drugs IPO subscribed 18.97x in total, whereas D.P.Abhushan IPO subscribed 41.60x.
| Beta Drugs IPO | D.P.Abhushan IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 29.93x | 67.95x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.00x | 15.24x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.97x | 41.60x |
